Literature DB >> 14079126

THE OPERATIVE APPROACH TO CONGENITAL AORTIC STENOSIS IN CHILDHOOD.

W T MUSTARD, G A TRUSLER, J YAO.   

Abstract

Forty-seven infants and children, aged from one month to 15 years, were operated upon during the past six years at the Hospital for Sick Children, Toronto, using extracorporeal circulation. Retrograde cardiac catheterization of the left ventricle with a pull-through tracing across the valve is important in selection of candidates for operation. Patients with a pressure gradient of over 45 mm. Hg require operation. In this series, valvular stenosis was the condition most commonly encountered; subvalvular membranous stenosis was present in eight patients, and muscular subvalvular stenosis in four. There was one operative death in an infant with multiple anomalies, and one late death from subacute bacterial endocarditis two years after operation. It is suggested that early operative treatment in cases of aortic stenosis in infancy and childhood might lessen the incidence of calcific aortic stenosis in adult life.

Entities:  

Keywords:  ADOLESCENCE; AORTIC VALVE STENOSIS; CANADA; CHILD; HEART SURGERY; INFANT; STATISTICS

Mesh:

Year:  1963        PMID: 14079126      PMCID: PMC1921942     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  The outlook for children with congenital aortic stenosis.

Authors:  I B BRAVERMAN; S GIBSON
Journal:  Am Heart J       Date:  1957-04       Impact factor: 4.749

2.  Congenital aortic stenosis and its surgical treatment.

Authors:  R M MARQUIS; A LOGAN
Journal:  Br Heart J       Date:  1955-07
  2 in total
  2 in total

1.  CONGENITAL AORTIC STENOSIS: SOME OBSERVATIONS ON THE NATURAL HISTORY AND CLINICAL ASSESSMENT.

Authors:  G B PECKHAM; J D KEITH; J R EVANS
Journal:  Can Med Assoc J       Date:  1964-09-19       Impact factor: 8.262

2.  THE PREOPERATIVE ASSESSMENT OF MULTIPLE VALVE DISEASE.

Authors:  D KAVANAGH-GRAY; A GERIEN
Journal:  Can Med Assoc J       Date:  1964-10-24       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.